Physician profile
Giuseppe Paese
NPI 1306882576
$179,710.62
in general payments reported to CMS, 2019-2025
46 companies · $31K in 2025
The $31K reported for 2025 was more than what 97% of Interventional Pain Medicine providers received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,892 · 2020: $2,153 · 2021: $7,780 · 2022: $102K · 2023: $19K · 2024: $12K · 2025: $31K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $22K · Education: $16K · Travel and Lodging: $13K · Food and Beverage: $7,686 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $4,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,750.00 |
| Education | $16,000.00 |
| Travel and Lodging | $12,685.35 |
| Food and Beverage | $7,685.87 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $4,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $138,831.90 | 2021-2025 | Ha Minuteman G3-R, Liberty Si |
| Elliquence, LLC | $14,959.00 | 2024-2025 | Disc-Fx System |
| Medtronic, INC. | $4,083.13 | 2021-2025 | Intellis Adaptivestim, Synchromedii |
| Orthofundamentals, LLC | $4,000.00 | 2023 | |
| Mml US, INC. | $3,701.51 | 2022 | |
| Medtronic USA, INC. | $3,633.65 | 2019-2020 | |
| Boston Scientific Corporation | $2,282.59 | 2019-2025 | Intracept, General - Pain Management, Wavewriter Alpha Prime 16 |
| Vertiflex, INC. | $2,142.74 | 2019 | |
| Relievant Medsystems, INC. | $1,260.49 | 2019-2023 | Intracept |
| Nalu Medical, INC. | $854.93 | 2021-2023 | Nalu Neurostimulation System |
| Saluda Medical Americas, INC. | $760.58 | 2023-2025 | Evoke, Evoke Scs |
| Globus Medical, INC. | $417.77 | 2025 | Senza |
| Si-Bone, INC. | $377.94 | 2019-2025 | |
| Amgen INC. | $210.37 | 2019-2024 | Evenity, Prolia |
| Stryker Corporation | $196.62 | 2019-2022 |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$188,947.44 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Giuseppe Paese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.